Anlon Healthcare Limited

Anlon Healthcare Limited (AHCL) is a micro-cap Healthcare company valued at ₹1,429 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Anlon Healthcare Limited last traded at ₹26.4, down 4.31% on the day.

Recent developments

2026-09-21, the company disclosed a material issue, which could impact its operations or financials. This development may raise concerns about the company's compliance or regulatory standing.

Financial performance

The company's business has improved significantly, with annual revenue rising 43.3% and annual net profit increasing 38.5% year-over-year. The latest quarter saw revenue surge 162.9% and net profit jump 133.2% compared to the same quarter a year earlier, though the net profit margin narrowed slightly to 16.9% from 17.5%.

Valuation multiples

The stock trades at 4.3 times earnings, a discount to the Healthcare median of 32.0, 4.05 times book value.

Things to watch

The company has not paid dividends despite reporting profits, which may indicate financial constraints or a focus on reinvestment. The net profit margin has also narrowed slightly, which could signal pressure on profitability. Additionally, domestic institutional holdings fell by 3.38 percentage points in the quarter, potentially indicating reduced confidence from large investors.

Where it stands

Anlon Healthcare Limited has shown strong growth in both revenue and net profit, with the latest quarter reflecting a significant increase compared to the same period last year. However, the company's decision not to pay dividends and the narrowing net profit margin highlight potential challenges. The most significant movement is the sharp rise in revenue and net profit in the latest quarter.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.